LHFPL1

gene
On this page

Summary

LHFPL1 (LHFPL tetraspan subfamily member 1, HGNC:6587) is a protein-coding gene on chromosome Xq23, encoding LHFPL tetraspan subfamily member 1 protein (Q86WI0).

This gene is a member of the lipoma HMGIC fusion partner (LHFP) gene family, which is a subset of the superfamily of tetraspan transmembrane protein encoding genes. Mutations in one LHFP-like gene result in deafness in humans and mice, and a second LHFP-like gene is fused to a high-mobility group gene in a translocation-associated lipoma. Alternatively spliced transcript variants have been found, but their biological validity has not been determined.

Source: NCBI Gene 340596 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 82 total
  • MANE Select transcript: NM_178175

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:6587
Approved symbolLHFPL1
NameLHFPL tetraspan subfamily member 1
LocationXq23
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000182508
Ensembl biotypeprotein_coding
OMIM300566
Entrez340596

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 8 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000371968, ENST00000478229, ENST00000864007, ENST00000864008, ENST00000864010, ENST00000922440, ENST00000922441, ENST00000922442, ENST00000922443

RefSeq mRNA: 1 — MANE Select: NM_178175 NM_178175

CCDS: CCDS14562

Canonical transcript exons

ENST00000371968 — 4 exons

ExonStartEnd
ENSE00001322535112660627112660725
ENSE00001456575112630648112631601
ENSE00001456578112671009112671404
ENSE00003844344112679829112679938

Expression profiles

Bgee: expression breadth ubiquitous, 108 present calls, max score 86.68.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2100 / max 26.5802, expressed in 81 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
2001990.210081

Top tissues by expression

212 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.68gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099174.60gold quality
nucleus accumbensUBERON:000188265.94gold quality
left coronary arteryUBERON:000162664.41gold quality
right coronary arteryUBERON:000162564.29gold quality
caudate nucleusUBERON:000187363.13gold quality
coronary arteryUBERON:000162163.09gold quality
descending thoracic aortaUBERON:000234560.10gold quality
putamenUBERON:000187459.68gold quality
hypothalamusUBERON:000189859.32gold quality
substantia nigraUBERON:000203859.07gold quality
medial globus pallidusUBERON:000247759.05silver quality
pituitary glandUBERON:000000758.57gold quality
thoracic aortaUBERON:000151558.13gold quality
ascending aortaUBERON:000149657.73gold quality
olfactory segment of nasal mucosaUBERON:000538657.51gold quality
amygdalaUBERON:000187657.24gold quality
adenohypophysisUBERON:000219657.23gold quality
midbrainUBERON:000189156.78gold quality
anterior cingulate cortexUBERON:000983555.98gold quality
globus pallidusUBERON:000187555.03silver quality
forebrainUBERON:000189053.65gold quality
right lobe of thyroid glandUBERON:000111953.26gold quality
left lobe of thyroid glandUBERON:000112052.86gold quality
thyroid glandUBERON:000204652.33gold quality
Brodmann (1909) area 9UBERON:001354051.79gold quality
brainUBERON:000095551.20gold quality
dorsolateral prefrontal cortexUBERON:000983451.11gold quality
right frontal lobeUBERON:000281050.68gold quality
temporal lobeUBERON:000187150.54gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.30

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

38 targeting LHFPL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6835-3P99.9370.492904
HSA-MIR-4799-5P99.8270.602663
HSA-MIR-6842-5P99.8067.541587
HSA-MIR-7110-5P99.8067.841712
HSA-MIR-4645-3P99.7669.33993
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-1255A99.7468.09744
HSA-MIR-1255B-5P99.7468.16741
HSA-MIR-442299.7272.072908
HSA-MIR-3059-5P99.7069.932491
HSA-MIR-450299.6566.991021
HSA-MIR-6752-5P99.5967.321243
HSA-MIR-6716-5P99.5668.621244
HSA-MIR-105-5P99.5469.242060
HSA-MIR-7853-5P99.5469.302055
HSA-MIR-312399.4767.152693
HSA-MIR-508-5P99.4164.251248
HSA-MIR-520F-5P99.3470.401632
HSA-MIR-4758-3P99.1263.96869
HSA-MIR-3675-3P99.0967.70968
HSA-MIR-474499.0169.911581
HSA-MIR-2355-5P98.8365.511589
HSA-MIR-500A-5P98.7669.131241
HSA-MIR-4722-5P98.4666.341611
HSA-MIR-6780A-3P98.4267.491518
HSA-MIR-4768-3P98.1666.022330
HSA-MIR-1212698.0964.82637
HSA-MIR-892B98.0067.11821
HSA-MIR-203B-3P97.8266.27979
HSA-MIR-5089-3P97.5067.82758

Literature-anchored findings (GeneRIF, showing 2)

  • Expressed widely in ER of all tissues, especially highly in lung, thymus, skeleton muscle, colon and ovary. (PMID:15620218)
  • The authors present an overview of the LHFP gene family in mouse and humans (PMID:15905332)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusLhfpl1ENSMUSG00000041700
rattus_norvegicusLhfpl1ENSRNOG00000027601

Paralogs (6): LHFPL2 (ENSG00000145685), LHFPL4 (ENSG00000156959), LHFPL6 (ENSG00000183722), LHFPL3 (ENSG00000187416), LHFPL5 (ENSG00000197753), LHFPL7 (ENSG00000206069)

Protein

Protein identifiers

LHFPL tetraspan subfamily member 1 proteinQ86WI0 (reviewed: Q86WI0)

Alternative names: Lipoma HMGIC fusion partner-like 1 protein

All UniProt accessions (1): Q86WI0

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Tissue specificity. Widely expressed. Expressed at high levels in lung, thymus, skeletal muscle, colon and ovary.

Similarity. Belongs to the LHFP family.

Isoforms (3)

UniProt IDNamesCanonical?
Q86WI0-11yes
Q86WI0-22
Q86WI0-33

RefSeq proteins (1): NP_835469* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR019372LHFPLFamily

Pfam: PF10242

UniProt features (8 total): transmembrane region 3, splice variant 2, signal peptide 1, chain 1, glycosylation site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86WI0-F189.470.70

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 153

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 54 (showing top): PAX4_01, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, CAGCTG_AP4_Q5, PAX8_B, TGCTGAY_UNKNOWN, WTGAAAT_UNKNOWN, ARGGGTTAA_UNKNOWN, LYF1_01, NKX22_01, NKX25_01, RYTTCCTG_ETS2_B, GATA4_Q3, CART1_01, MEF2_Q6_01, PAX6_01

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

370 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LHFPL1AMOTQ4VCS5617
LHFPL1RTL4Q6ZR62613
LHFPL1LRCH2Q5VUJ6580
LHFPL1UBE4BO95155570
LHFPL1LRRK1Q38SD2516
LHFPL1ALG13Q9NP73487
LHFPL1TRPC5Q9UL62456
LHFPL1ANKRD40Q6AI12446
LHFPL1HTR2CP28335415
LHFPL1NXPE2Q96DL1400
LHFPL1CTCFP49711394
LHFPL1CEACAM20Q6UY09393
LHFPL1RBP7Q96R05386
LHFPL1ATRXP46100353
LHFPL1TGM5O43548329

IntAct

18 interactions, top by confidence:

ABTypeScore
LATLHFPL1psi-mi:“MI:0915”(physical association)0.560
LHFPL1THSD7Apsi-mi:“MI:0915”(physical association)0.560
PLP2LHFPL1psi-mi:“MI:0915”(physical association)0.560
IGFBP5LHFPL1psi-mi:“MI:0915”(physical association)0.560
SEC22BLHFPL1psi-mi:“MI:0915”(physical association)0.560
LHFPL1TSPAN10psi-mi:“MI:0915”(physical association)0.400
LHFPL1ADCY3psi-mi:“MI:0914”(association)0.350
THSD7ALHFPL1psi-mi:“MI:0915”(physical association)0.000
PLP2LHFPL1psi-mi:“MI:0915”(physical association)0.000
LATLHFPL1psi-mi:“MI:0915”(physical association)0.000
IGFBP5LHFPL1psi-mi:“MI:0915”(physical association)0.000
SEC22BLHFPL1psi-mi:“MI:0915”(physical association)0.000

BioGRID (12): LHFPL1 (Two-hybrid), LHFPL1 (Two-hybrid), LHFPL1 (Two-hybrid), LAT (Two-hybrid), SEC22B (Two-hybrid), TSPAN10 (Affinity Capture-MS), TMEM259 (Affinity Capture-MS), RNF185 (Affinity Capture-MS), BSCL2 (Affinity Capture-MS), OSBPL5 (Affinity Capture-MS), ADCY3 (Affinity Capture-MS), SLC27A3 (Affinity Capture-MS)

ESM2 similar proteins: A0A1D5NY17, A4IF75, B2RVY9, B3SHH9, F6V1J6, O42281, O70578, P19518, P97707, Q06432, Q08CE6, Q08DE1, Q0D289, Q0V9E0, Q14714, Q2MJQ7, Q4R4Z3, Q4V922, Q5CZV0, Q5PRC1, Q5RDV7, Q5XGU1, Q62147, Q66IV3, Q68FV0, Q6AZD1, Q6P0C6, Q6R5J2, Q6ZP80, Q6ZUX7, Q7ZZL8, Q86WI0, Q8BGA2, Q8NBL3, Q8VHW3, Q8VHW4, Q8VHW7, Q8VHW8, Q91Y55, Q925N4

Diamond homologs: Q5BJS2, Q5PRC1, Q6P0C6, Q80SV1, Q80WE5, Q86WI0, Q8BM86, Q9Y693, Q6DHB5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

82 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance23
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1059 predictions. Top by Δscore:

VariantEffectΔscore
X:112631598:GTACC:Gacceptor_loss0.9800
X:112631599:TACCT:Tacceptor_loss0.9800
X:112631601:CCTGT:Cacceptor_loss0.9800
X:112631602:CT:Cacceptor_loss0.9800
X:112631603:T:Cacceptor_loss0.9800
X:112648638:CAAAG:Cdonor_gain0.9800
X:112653585:T:TAdonor_gain0.9800
X:112631604:G:Cacceptor_loss0.9700
X:112632984:C:Adonor_gain0.9700
X:112632344:C:CTdonor_gain0.9600
X:112671004:CTTA:Cdonor_loss0.9600
X:112671005:TTA:Tdonor_loss0.9600
X:112671006:TA:Tdonor_loss0.9600
X:112671007:A:ATdonor_loss0.9600
X:112632941:T:TAdonor_gain0.9400
X:112632339:CCCCG:Cdonor_gain0.9300
X:112632340:CCCGC:Cdonor_gain0.9300
X:112632341:CCGCC:Cdonor_gain0.9300
X:112632345:C:CTdonor_gain0.9300
X:112653591:T:Adonor_gain0.9300
X:112671405:C:CCacceptor_gain0.9300
X:112662415:ATTG:Adonor_gain0.9200
X:112662418:G:Adonor_gain0.9200
X:112632916:T:Adonor_gain0.9100
X:112646161:T:TAdonor_gain0.9000
X:112679824:TTTA:Tdonor_loss0.9000
X:112679825:TTACC:Tdonor_loss0.9000
X:112679826:TAC:Tdonor_loss0.9000
X:112679827:AC:Adonor_loss0.9000
X:112679828:C:Adonor_loss0.9000

AlphaMissense

1427 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
X:112660684:A:GW142R0.997
X:112660684:A:TW142R0.997
X:112671256:G:CS45R0.997
X:112671256:G:TS45R0.997
X:112671258:T:GS45R0.997
X:112660682:C:AW142C0.996
X:112660682:C:GW142C0.996
X:112660712:G:CS132R0.996
X:112660712:G:TS132R0.996
X:112660714:T:GS132R0.996
X:112671313:A:CS26R0.996
X:112671313:A:TS26R0.996
X:112671315:T:GS26R0.996
X:112660634:A:CF158L0.995
X:112660634:A:TF158L0.995
X:112660636:A:GF158L0.995
X:112671119:C:TG91D0.995
X:112671150:A:GW81R0.995
X:112671150:A:TW81R0.995
X:112671248:C:GR48P0.995
X:112671322:A:CS23R0.995
X:112671322:A:TS23R0.995
X:112671324:T:GS23R0.995
X:112660656:C:TC151Y0.994
X:112660696:A:CY138D0.994
X:112671148:C:AW81C0.994
X:112671148:C:GW81C0.994
X:112671157:G:CS78R0.994
X:112671157:G:TS78R0.994
X:112671159:T:GS78R0.994

dbSNP variants (sampled 300 via entrez): RS1000011519 (X:112633350 C>A), RS1000031867 (X:112643391 A>G), RS1000050467 (X:112676590 C>T), RS1000103675 (X:112642813 T>A,C), RS1000120920 (X:112658695 A>C), RS1000281200 (X:112653559 C>T), RS1000304682 (X:112662189 T>C), RS1000309222 (X:112681149 T>G), RS1000376621 (X:112661813 C>G,T), RS1000479480 (X:112651683 T>C), RS1000502736 (X:112672192 T>C), RS1000535705 (X:112672793 C>A,G), RS1000634118 (X:112660478 C>T), RS1000648419 (X:112678826 G>C), RS1000791561 (X:112670004 T>A,C)

Disease associations

OMIM: gene MIM:300566 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases methylation, increases methylation, decreases expression2
bisphenol Aincreases methylation1
trichostatin Aincreases expression1
CGP 52608affects binding, increases reaction1
Diethylhexyl Phthalatedecreases expression1
Silicon Dioxideincreases expression1
Valproic Acidincreases expression1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.